Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Dexter

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2013
Transmission of multiple system atrophy prions to transgenic miceJoel C Watts, Kurt Giles, Abby Oehler, et al.
Molecular Neurodegeneration|September 24, 2015
Pharmacogenetic stimulation of cholinergic pedunculopontine neurons reverses motor deficits in a rat model of Parkinson's diseaseIlse S Pienaar, Sarah E Gartside, Puneet Sharma, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 18, 2010
Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson's disease after peripheral administrationDavid T Dexter, Sarah A Statton, Charlotte Whitmore, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 23, 2020
DREADD Activation of Pedunculopontine Cholinergic Neurons Reverses Motor Deficits and Restores Striatal Dopamine Signaling in Parkinsonian RatsPuneet K Sharma, Lisa Wells, Gaia Rizzo, et al.
ACS Applied Materials & Interfaces|October 24, 2017
Multibranched Gold Nanoparticles with Intrinsic LAT-1 Targeting Capabilities for Selective Photothermal Therapy of Breast CancerZhan Yuin Ong, Shu Chen, Elham Nabavi, et al.
Nanoscale|November 14, 2019
Quantification of blood-brain barrier transport and neuronal toxicity of unlabelled multiwalled carbon nanotubes as a function of surface chargeDaniel Gonzalez-Carter, Angela E Goode, Darya Kiryushko, et al.
Archives of Toxicology|February 21, 2020
Novel 1-hydroxypyridin-2-one metal chelators prevent and rescue ubiquitin proteasomal-related neuronal injury in an in vitro model of Parkinson's diseaseFrank W Lewis, Safiya Fairooz, Joanna L Elson, et al.
Journal of Parkinson'S Disease|August 9, 2024
A Coalition to Advance Treatments for Parkinson's Disease, Dementia with Lewy Bodies, and Related DisordersCatherine M Kopil, Angelica Asis, Clyde Campbell, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 13, 2015
BrainNet Europe's Code of Conduct for brain bankingNatasja M Klioueva, Marleen C Rademaker, David T Dexter, et al.
Scientific Reports|May 5, 2017
Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's diseaseAntonio Martin-Bastida, Roberta J Ward, Rexford Newbould, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2013
Transmission of multiple system atrophy prions to transgenic miceJoel C Watts, Kurt Giles, Abby Oehler, et al.
Molecular Neurodegeneration|September 24, 2015
Pharmacogenetic stimulation of cholinergic pedunculopontine neurons reverses motor deficits in a rat model of Parkinson's diseaseIlse S Pienaar, Sarah E Gartside, Puneet Sharma, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 18, 2010
Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson's disease after peripheral administrationDavid T Dexter, Sarah A Statton, Charlotte Whitmore, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 23, 2020
DREADD Activation of Pedunculopontine Cholinergic Neurons Reverses Motor Deficits and Restores Striatal Dopamine Signaling in Parkinsonian RatsPuneet K Sharma, Lisa Wells, Gaia Rizzo, et al.
ACS Applied Materials & Interfaces|October 24, 2017
Multibranched Gold Nanoparticles with Intrinsic LAT-1 Targeting Capabilities for Selective Photothermal Therapy of Breast CancerZhan Yuin Ong, Shu Chen, Elham Nabavi, et al.
Nanoscale|November 14, 2019
Quantification of blood-brain barrier transport and neuronal toxicity of unlabelled multiwalled carbon nanotubes as a function of surface chargeDaniel Gonzalez-Carter, Angela E Goode, Darya Kiryushko, et al.
Archives of Toxicology|February 21, 2020
Novel 1-hydroxypyridin-2-one metal chelators prevent and rescue ubiquitin proteasomal-related neuronal injury in an in vitro model of Parkinson's diseaseFrank W Lewis, Safiya Fairooz, Joanna L Elson, et al.
Journal of Parkinson'S Disease|August 9, 2024
A Coalition to Advance Treatments for Parkinson's Disease, Dementia with Lewy Bodies, and Related DisordersCatherine M Kopil, Angelica Asis, Clyde Campbell, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 13, 2015
BrainNet Europe's Code of Conduct for brain bankingNatasja M Klioueva, Marleen C Rademaker, David T Dexter, et al.
Scientific Reports|May 5, 2017
Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's diseaseAntonio Martin-Bastida, Roberta J Ward, Rexford Newbould, et al.
Pageof 7